ITNS Insider
Oct. 8, 2015

2016 Abstracts Due Oct. 12
Submit an abstract before the Oct. 12, 2015 deadline. Share your knowledge for the benefit of the transplant nursing community. Questions about abstract submission? Contact Olivia Schmit, Education Administrator, at

New England Chapter of ITNS Fall Meeting

When: Tuesday Oct. 20, 2015
Where: Bertucci’s Restaurant, 4054 Mystic Valley Parkway, Medford, MA 02155
Time: 7:00 p.m.
Pre-Registration Price: $20.00
Door Price: $25.00
To register: Please send RSVP to NewEnglandITNS@gmail.comMore

Transplant Exam Study Session

Presented by: Linda Ohler, MSN, RN, CCTC, FAAN and Sandra Cupples, PhD, RN, FAAN, authors of Transplantation Nursing Secrets and Core Curriculum for Transplant Nurses
Location: Kaiser Permanente, 11921-D Bournefield Way, Silver Spring, Maryland 20904
Date: Nov. 7, 2015 from 9 a.m. until 5 p.m.
Cost: $25 for current ITNS International and Local Chapter Members, $150 for Non-members
Registration: To attend, send an email to caroline.acker@ymail.comMore

Featured transplant articles
Read recently published articles from The Journal of Heart and Lung Transplantation, American Journal of Transplantation, Pediatric Transplantation, Liver Transplantation, and Transplantation. Click here to read the abstracts and for links to the full articles.More

Sign up for a SIG Listserv
Visit and click "Login" to access the Members Only section of the website.

For more information, check out the SIG Listserv Frequently Asked Questions (FAQs).More

3-D printing aids heart transplant in US
Surgeons in the U.S. have carried out a successful heart transplant on a five-year-old girl using 3D printing to help them. They used a model of her heart to work out exactly how they needed to operate cutting down the length of the procedure. It is thought it could increase a patient's chance of survival in future.More

Genome wide testing may make transplantation more personalized
Medical Research
Genetic studies in transplantation have been plagued by small samples and very complex phenotypes/outcomes of patients. Transplanted individuals are typically on potent immunosuppression drugs for the rest of their lives, as they have 3.5 million to 10 million variants difference from an unrelated transplanted donor organ. Such populations would certainly benefit from large well-powered genetic studies but only 3 transplant genome-wide genotyping studies comprising a few hundred individuals have been published.More

New formula predicts liver volume for live donor liver transplantation
A new formula developed by researchers in Switzerland and Japan was accurate in calculating standard liver volume in recipients of living donor liver transplantation, according to study data published in the Journal of Hepatology. To create this formula, liver volumes of 180 Japanese donor candidates from a tertiary care Japanese hospital between March 2006 and December 2013 and 160 Swiss patients with normal livers treated at a tertiary care Swiss hospital between January 2001 and April 2014 were analyzed by researchers.More

Ovarian tissue transplant can help some women have kids after cancer treatment
Health Day
Cancer patients who have ovarian tissue removed and stored for later transplantation have a chance at a successful pregnancy, a new study finds. Powerful chemotherapy and radiation treatments for cancer can impair a woman's fertility. This new study shows that ovarian tissue transplants are safe and effective and pose little risk of the cancer coming back, the Danish researchers said.More

Britain to see its first womb transplants as procedure gets official approval
Tech Times
Ten women in the United Kingdom will get womb transplants as part of a clinical trial approved by the country's Health Research Authority following successful procedures in Sweden. Doctors at Imperial College London have been given the go-ahead to carry out the transplants as part of the clinical trial, which, if successful, could see Britain's first babies born from womb transplants in late 2017 or 2018.More

Scientists develop fast-pumping artificial foam heart
Scientists have developed a soft, foam-based artificial heart which can pump at a faster rate than any similar alternatives. The proof-of-concept heart is made of flexible, porous silicone and is an example of soft robotics, which move by allowing compressed air to flow through the material, according to New Scientist magazine. Many of the current artificial hearts approved by the U.S. Food and Drug Administration (FDA), which tests medical devices, are hard devices that are attached to external pumps, such as the SynCardia Total Artificial Heart.More

Probiotics reduce rate of infection after liver transplant
Doctors Lounge
Liver transplant recipients have a lower rate of infection with receipt of prebiotics and probiotics before surgery, according to a meta-analysis published in the issue of Clinical Gastroenterology and Hepatology. Tarek Sawas, M.D., from the Medical College of Wisconsin in Milwaukee, and colleagues conducted a meta-analysis to examine the impact of prebiotics and probiotics on infections in patients receiving liver transplants. More

Study: Burnout impacts transplant nurses
More than half of nurses who work with organ transplant patients in the United States experience high levels of emotional exhaustion, a primary sign of burnout, according to a study published by researchers at Henry Ford Hospital. In addition, 52 percent of the nurses surveyed reported feeling low levels of personal accomplishment in their life-saving work, according to findings published recently in Progress in Transplantation, the official journal of NATCO. More

Vitebsk surgeons make first aorta transplantation
The operation was made on a 75-year-old patient. Vitebsk surgeons applied the technology developed by Cardiology center. Such complicated operations have been performed only in Minsk. Nikolai Loiko, surgeon of Cardiosurgery Department of Vitebsk Clinical Hospital: "The operation is unique. It took us 4.5 hours to perform it. Now we are performing the rehabilitation treatment." More

Liver transplantation prolongs DFS in pediatric HBL, HCC
Liver transplantation combined with chemotherapy provided long-term DFS in pediatric patients with advanced hepatoblastoma and hepatocellular carcinoma, according to the results of a retrospective analysis. Favorable outcomes with transplantation persisted even among patients with hepatocellular carcinoma (HCC) larger than Milan and University of California, San Francisco (UCSF) criteria for transplant eligibility, results also showed.More